Closing Bell: Medicenna Therapeutics Corp flat on Tuesday (MDNA)

In trading today, Medicenna Therapeutics Corp shares closed at $1.95 after opening the day at $1.96. It traded at a low of $1.92 to a high of $1.96.

The price $verbed percentage_change percent from the previous day's close of $1.95.

Today across North America, the TSX Composite closed -0.26% at 22813.75, the S&P 500 closed 1.08% at 5564.41, the Dow Jones Industrial Average closed 0.32% at 40415.44 and the Nasdaq Composite closed 1.58% at 18007.57.

Medicenna Therapeutics Corp traded under MDNA on the Toronto Stock Exchange (TSX).

Trading volume was 32,276 on 77 total trades, with an average volume of 51,460 over 5 days.

Trading across the entire TSX saw 3,093 price advancers against 2,137 declines and 96 unchanged.

During the prior 52 weeks, MDNA.TO has traded as high as $2.98 (June 03,2024) and low as $0.22 (November 01,2023). Moreover, in the last 52 weeks, Medicenna Therapeutics Corp's shares have risen 248.21 percent, while they have risen 364.29% since the start of 2024.

Following today's trading, Medicenna Therapeutics Corp has a market capitalization of $145.82 million on a float of 74,779 shares outstanding. Its annual EPS is $-0.23.

Medicenna Therapeutics Corp is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Medicenna Therapeutics Corp's consensus rating is "Strong Buy" based on 2 analysts according to Zacks. From those 2 analysts, 2 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..